| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |